Covid Vaccine Update: Nasal Vaccines a Sniffing Hope Dr SK Gupta8 Sep 2022 8:28 AM GMTCovid Vaccine Update Nasal Vaccines—Sniffing Hope World seems to be moving towards centuries old technique of Sniffing Vaccines. In 18th Century...
Bharat Biotech Covaxin booster dose broadens immunity against Delta, Omicron variants: ICMR study Ruchika Sharma15 Jun 2022 10:45 AM GMTNew Delhi: The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection...
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 8:15 AM GMTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Africa to get BioNTech mRNA vaccine factory soon Ruchika Sharma12 Jun 2022 3:30 AM GMTBioNTech has said the BioNTainers could make other mRNA vaccines against malaria or tuberculosis, depending on product development progress and future...
Moderna coronavirus vaccine effective for kids under five years: USFDA Ruchika Sharma11 Jun 2022 8:45 AM GMTEven though Moderna's vaccine has proven less effective against the Omicron variant, it remains very good at protecting against severe cases of the...
FIRST: COVID vaccine for animals launched in India Ruchika Sharma11 Jun 2022 7:50 AM GMTThe vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant. It is safe for dogs, lions, leopards, mice and rabbits, it...
Bivalent booster demonstrates superior antibody response against Omicron: Moderna Ruchika Sharma9 Jun 2022 9:47 AM GMT"Moderna is planning to submit the interim analysis and data to regulators for review in the coming weeks," the company further stated.
Novavax COVID shot gets USFDA Advisory Committee recommendation for emergency use nod for 18 years and older Ruchika Sharma8 Jun 2022 6:44 AM GMTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19
SII to produce Novavax COVID vaccine for US Ruchika Sharma8 Jun 2022 4:30 AM GMTNew Delhi: Novavax Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the...
JnJ to terminate COVID vaccine agreement with Emergent BioSolutions Ruchika Sharma7 Jun 2022 11:03 AM GMTIf the agreement is terminated, Emergent said J&J would owe it roughly $125 million to $420 million.
Bharat Biotech Covaxin to be recognized in Germany for travel from June 1 Ruchika Sharma28 May 2022 4:00 AM GMTCovaxin is a ready-to-use liquid vaccine, stored at 2-8 degrees Celsius, with 12 months shelf life and a multi-dose vial policy.
Vaccine maker SII to set up first manufacturing plant in Africa Ruchika Sharma25 May 2022 5:45 AM GMTAsked about possible investments, Poonawalla said such projects typically required at least around $300 million.
